These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11557168)

  • 21. The neuroendocrine and behavioral response to dextroamphetamine in normal individuals.
    Dommisse CS; Schulz SC; Narasimhachari N; Blackard WG; Hamer RM
    Biol Psychiatry; 1984 Sep; 19(9):1305-15. PubMed ID: 6149772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single dose of prednisone does not induce amphetamine-like subjective effects in healthy subjects.
    Warot D; Danjou P; Payan C; Rocher J; Brialy N; Puech AJ
    Therapie; 1995; 50(4):307-12. PubMed ID: 7482385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Riluzole and D-amphetamine interactions in humans.
    Sofuoglu M; Waters AJ; Mooney M; Kosten T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):16-22. PubMed ID: 17714844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
    Jayaram-Lindström N; Konstenius M; Eksborg S; Beck O; Hammarberg A; Franck J
    Neuropsychopharmacology; 2008 Jul; 33(8):1856-63. PubMed ID: 17957221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human sex differences in d-amphetamine self-administration.
    Vansickel AR; Stoops WW; Rush CR
    Addiction; 2010 Apr; 105(4):727-31. PubMed ID: 20148783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subjective responses predict d-amphetamine choice in healthy volunteers.
    Murray CH; Li J; Weafer J; de Wit H
    Pharmacol Biochem Behav; 2021 May; 204():173158. PubMed ID: 33675838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced appetitive conditioning following repeated pretreatment with d-amphetamine.
    Harmer CJ; Phillips GD
    Behav Pharmacol; 1998 Jul; 9(4):299-308. PubMed ID: 10065918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personality and gender differences in effects of d-amphetamine on risk taking.
    White TL; Lejuez CW; de Wit H
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):599-609. PubMed ID: 18179313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse.
    Jasinski DR; Krishnan S
    J Psychopharmacol; 2009 Jun; 23(4):419-27. PubMed ID: 19329547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.
    Brauer LH; De Wit H
    Pharmacol Biochem Behav; 1997 Feb; 56(2):265-72. PubMed ID: 9050084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are attention lapses related to d-amphetamine liking?
    McCloskey M; Palmer AA; de Wit H
    Psychopharmacology (Berl); 2010 Feb; 208(2):201-9. PubMed ID: 19936714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sweet taste liking is associated with subjective response to amphetamine in women but not men.
    Weafer J; Lyon N; Hedeker D; de Wit H
    Psychopharmacology (Berl); 2017 Nov; 234(21):3185-3194. PubMed ID: 28762072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute administration of d-amphetamine decreases impulsivity in healthy volunteers.
    de Wit H; Enggasser JL; Richards JB
    Neuropsychopharmacology; 2002 Nov; 27(5):813-25. PubMed ID: 12431855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verbal memory improved by D-amphetamine: influence of the testing effect.
    Zeeuws I; Deroost N; Soetens E
    Hum Psychopharmacol; 2010 Jul; 25(5):377-87. PubMed ID: 20589927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis: implications for a sensitization model of psychosis in humans.
    Strakowski SM; Sax KW; Setters MJ; Stanton SP; Keck PE
    Biol Psychiatry; 1997 Nov; 42(9):749-55. PubMed ID: 9347122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subjective responses to amphetamine in young adults with previous mood elevation experiences.
    Schepers ST; Arndt DL; Rogers RD; Hedeker D; de Wit H
    Psychopharmacology (Berl); 2019 Nov; 236(11):3363-3370. PubMed ID: 31209507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of mixtures of morphine and d-amphetamine for subjective and physiological effects.
    Jasinski DR; Preston KL
    Drug Alcohol Depend; 1986 May; 17(1):1-13. PubMed ID: 3720527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans.
    Strakowski SM; Sax KW
    Biol Psychiatry; 1998 Dec; 44(11):1171-7. PubMed ID: 9836021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers.
    Grady TA; Broocks A; Canter SK; Pigott TA; Dubbert B; Hill JL; Murphy DL
    Psychiatry Res; 1996 Aug; 64(1):1-10. PubMed ID: 8888359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similar discriminative-stimulus effects of D-amphetamine in women and men.
    Vansickel AR; Lile JA; Stoops WW; Rush CR
    Pharmacol Biochem Behav; 2007; 87(2):289-96. PubMed ID: 17561238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.